柏柏林调节肠道微生物组和新陈代谢恒常性,用于治疗性结肠炎
Tao Yang1, Niping Qin2, Fahui Liu3
1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.
Life sciences
|January 6, 2024
概括
柏柏林 (BBR) 治疗改善了性结肠炎 (UC) 模型中的肠道微生物平衡和血清代谢健康. 它通过调节肠道微生物群和抑制酸通路来实现这一目标,为UC提供了一种新的治疗方法.
科学领域:
- 微生物学 微生物学
- 代谢学 代谢学 代谢学
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种具有复杂病因的慢性炎症性肠病.
- 肠道微生物组 (IM) 和血清代谢组在UC病变发生过程中起着至关重要的作用.
- 柏柏林 (BBR) 是一种具有潜在治疗功能的天然化合物.
研究的目的:
- 研究BBR对UC的IM和血清代谢基因组的影响.
- 阐明BBR在治疗UC中的有效性背后的分子机制.
- 探索BBR,IM和宿主新陈代谢之间的相互作用.
主要方法:
- 一种集成16S rDNA测序,血清代谢学和转录学的多omics方法.
- 柏柏林诱导的便微生物群移植 (BBR_FMT) 在UC小鼠模型中.
- 基因表达的验证使用实时PCR和西方布洛特.
主要成果:
- BBR调节了IM,增加了诸如Bacteroides和Akkermansia这样的有益细菌.
- BBR治疗使血清代谢概况正常化,并减少与炎症相关的代谢物.
- BBR_FMT抑制了阿拉基酸 (AA) 代谢途径,与改善的IM和减少炎症相关.
结论:
- BBR通过调节肠道微生物群来改善血清代谢平衡.
- 抑制AA代谢途径是BBR在UC治疗效果的关键机制.
- BBR代表了对UC的有希望的治疗剂,通过向肠道微生物群和宿主新陈代谢.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
144
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
144
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:26Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
430
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
01:29Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
187
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
187